USPTO serial 79401859
LNJ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 10, 2025
- Examiner
- POWERS, ALEXANDER L
- Law office
- GENERIC WEB UPDATE
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LNJ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yan Song
Yan Song AEON Law, PLLC1718 E. Olive WaySeattle, WA 98102United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of brain disease using technology capable of passing through the blood-brain barrier to deliver therapeutic proteins directly to brain tissue, using the dual action therapy platform for medical purposes; pharmaceutical preparations for the treatment of Alzheimer's disease; pharmaceutical preparations for the treatment of brain disease for medical purposes; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of neurodegenerative brain diseases for medical purposes; pharmaceutical preparations for the treatment of Parkinson's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses | ACTIVE | — |
| 042 | Scientific research in the nature of conducting clinical trials for others in the field of brain and central nervous system diseases; research and development of vaccines and medicines; development of cell therapy products; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services for predicting disease; medical research laboratory services in the field of the blood-brain barrier; medical research laboratory services in the field of Alzheimer's disease; none of the foregoing related to the treatment of vaccinia and orthopox viruses | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 22, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 13, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 13, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 7, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 7, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 10, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 10, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 10, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 18, 2025 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 17, 2025 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Apr 17, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 17, 2025 | APET | ASSIGNED TO PETITION STAFF | — |
| Mar 13, 2025 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 6, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Jan 7, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 7, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 1, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 11, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 11, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 4, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 19, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 8, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |